Search Orphan Drug Designations and Approvals
-
Generic Name: | nitric oxide |
---|---|
Date Designated: | 12/28/2011 |
Orphan Designation: | Treatment of pulmonary arterial hypertension |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Bellerophon Therapeutics 53 Frontage Road Suite 301 Hampton, New Jersey 08827 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-